Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Glutamic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 known ✓ | P39086 | 1/20 | 0.90 |
| ▸ | GRIA1 known ✓ | P42261 | 1/20 | 0.90 |
| ▸ | GRIA2 known ✓ | P42262 | 1/20 | 0.90 |
| ▸ | GRIA3 known ✓ | P42263 | 1/20 | 0.90 |
| ▸ | GRIA4 known ✓ | P48058 | 1/20 | 0.90 |
| ▸ | GRIN2A known ✓ | Q12879 | 1/20 | 0.90 |
| ▸ | GRIK2 known ✓ | Q13002 | 1/20 | 0.90 |
| ▸ | GRIK3 known ✓ | Q13003 | 1/20 | 0.90 |
| ▸ | GRIK5 known ✓ | Q16478 | 1/20 | 0.90 |
| ▸ | GRM8 | O00222 | 2/20 | 0.90 |
| ▸ | GRM6 | O15303 | 2/20 | 0.90 |
| ▸ | GRM7 | Q14831 | 2/20 | 0.90 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.90 |
| ▸ | GSR | P00390 | 2/20 | 0.90 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.90 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.90 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.90 |
| ▸ | GRM5 | P41594 | 1/20 | 0.90 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.90 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.90 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| D-Glutamate SCHEMBL2828267 | 1.00 | GRM8 (0.90) | GRM8GRM6GRM7GRM4GSR | |
| D-Glutamate SCHEMBL10427323 | 1.00 | GRM8 (0.90) | GRM8GRM6GRM7GRM4GSR | |
| D-Glutamate SCHEMBL2586884 | 0.97 | GRM8 (0.95) | GRM8GRM6GRM7GRM4GSR | |
| Glutamic Acid SCHEMBL5605606 | 0.97 | GRM8 (0.95) | GRM8GRM6GRM7GRM4GSR | |
| Glutamic Acid SCHEMBL161675 | 0.97 | GRM8 (0.95) | GRM8GRM6GRM7GRM4GSR | |
| D-Glutamate SCHEMBL910049 | 0.97 | GRM8 (0.95) | GRM8GRM6GRM7GRM4GSR | |
| Glutamic Acid SCHEMBL8530554 | 0.97 | GRM8 (0.95) | GRM8GRM6GRM7GRM4GSR | |
| Glutamic Acid SCHEMBL5605825 | 0.97 | GRM8 (0.95) | GRM8GRM6GRM7GRM4GSR | |
| D-Glutamate SCHEMBL21638311 | 0.97 | GRM8 (0.95) | GRM8GRM6GRM7GRM4GSR | |
| D-Glutamate SCHEMBL2880987 | 0.97 | GRM8 (0.95) | GRM8GRM6GRM7GRM4GSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8623422-B2 | Combination treatment with strontium for the prophylaxis and/or treatment of cartilage and/or bone conditions | OSTEOLOGIX A/S (DK) | 2014-01-07 | — | — | US | disclosed |
| US-8541471-B2 | Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions | OSTEOLOGIX A/S (DK) | 2013-09-24 | — | — | US | disclosed |
| EP-1622629-B1 | Controlled-release composition containing a strontium salt | OSTEOLOGIX AS (DK) | 2013-07-10 | — | — | EP | disclosed |
| EP-1745791-B1 | Treating cartilage/bone conditions with water-soluble strontium salts | OSTEOLOGIX AS (DK) | 2013-06-26 | — | — | EP | disclosed |
| EP-2266585-B1 | Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions | OSTEOLOGIX AS (DK) | 2013-06-26 | — | — | EP | disclosed |
| US-20130071496-A1 | CONTROLLED RELEASE COMPOSITION CONTAINING A STRONTIUM SALT | OSTEOLOGIX A/S (DK) | 2013-03-21 | — | — | US | disclosed |
| EP-2266584-B1 | Composition with strontium and vitamin D for the prophylaxis and/or treatment of cartilage and/or bone conditions | OSTEOLOGIX AS (DK) | 2012-09-05 | — | — | EP | disclosed |
| EP-1622630-B1 | STRONTIUM COMBINATIONS FOR THE PROPHYLAXIS/TREATMENT OF CARTILAGE AND/OR BONE CONDITIONS | OSTEOLOGIX AS (DK) | 2012-08-29 | — | — | EP | disclosed |
| US-8183409-B2 | High yield and rapid synthesis methods for producing metallo-organic salts | OSTEOLOGIX A/S (DK) | 2012-05-22 | — | — | US | disclosed |
| EP-2266585-A2 | Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions | Osteologix A/S (DK) | 2010-12-29 | — | — | EP | disclosed |
| EP-1534305-B1 | TREATING CARTILAGE / BONE CONDITIONS WITH WATER-SOLUBLE STRONTIUM SALTS | OSTEOLOGIX AS (DK) | 2006-10-18 | — | — | EP | disclosed |
| US-20060216358-A1 | Controlled release composition containing a strontium salt | OSTEOLOGIX A/S (DK) | 2006-09-28 | — | — | US | disclosed |
| US-20060122274-A1 | Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions | OSTEOLOGIX A/S (DK) | 2006-06-08 | — | — | US | disclosed |
| EP-1622630-A2 | STRONTIUM COMBINATIONS FOR THE PROPHYLAXIS/TREATMENT OF CARTILAGE AND/OR BONE CONDITIONS | Osteologix A/S (DK) | 2006-02-08 | — | — | EP | disclosed |
| EP-1622629-A2 | CONTROLLED RELEASE COMPOSITION CONTAINING A STRONTIUM SALT | Osteologix A/S (DK) | 2006-02-08 | — | — | EP | disclosed |
| WO-2005108339-A2 | HIGH YIELD AND RAPID SYNTHESES METHODS FOR PRODUCING METALLO-ORGANIC SALTS | OSTEOLOGIX A/S (DK) | 2005-11-17 | — | — | WO | disclosed |
| EP-1534305-A2 | TREATING CARTILAGE / BONE CONDITIONS WITH WATER-SOLUBLE STRONTIUM SALTS | Osteologix A/S (DK) | 2005-06-01 | — | — | EP | disclosed |
| WO-2004098619-A2 | TREATING CARTILAGE / BONE CONDITIONS WITH WATER-SOLUBLE STRONTIUM SALTS | OSTEOLOGIX A/S (DK) | 2004-11-18 | — | — | WO | disclosed |
| WO-2004098618-A2 | STRONTIUM COMBINATIONS FOR PROPHYLAXIS/TREATMENT OF CARTILAGE AND/OR BONE CONDITIONS | OSTEOLOGIX A/S (DK) | 2004-11-18 | — | — | WO | disclosed |
| WO-2004098617-A2 | CONTROLLED RELEASE COMPOSITION CONTAINING A STRONTIUM SALT | OSTEOLOGIX A/S (DK) | 2004-11-18 | — | — | WO | disclosed |